WeVote
Log In

Bill

Bill

SR 144

A RESOLUTION designating March 31, 2026, as Kentucky Translational Science Day in the Commonwealth.

2026 Regular Session Introduced by Amanda Bledsoe

Designates March 31, 2026 as Kentucky Translational Science Day to recognize the University of Kentucky’s leadership and the translational science effort improving public health in

adopted by voice vote
#commendationsandrecognitions #education #higher #scienceandtechnology
0
WeVote Research Nonpartisan
Bill Summary · SR 144

Summary of SR 144 (2026RS) – Kentucky Translational Science Day

What the bill does

  • Designates March 31, 2026, as “Kentucky Translational Science Day” in the Commonwealth of Kentucky.

Purpose and intent

  • To recognize and highlight the University of Kentucky’s (UK) role in translational science—the process of turning scientific discoveries into practical interventions that improve public health.
  • To acknowledge UK as Kentucky’s flagship university with multidisciplinary capacity to address major health challenges through translational research.
  • To emphasize the importance of the University of Kentucky Center for Clinical and Translational Science (CCTS) as a key engine for translating research into clinical practice, prevention, and community health improvements.
  • To publicly affirm Kentucky’s commitment to supporting researchers, staff, and community partners involved in translational science and related health innovations.

Key provisions

  • Section 1: Official designation of March 31, 2026, as Kentucky Translational Science Day.
  • Section 2: Directs the Clerk of the Senate to transmit a copy of the resolution to Senator Amanda Mays Bledsoe (co-sponsor).

Who or what is affected

  • Primarily a commemorative designation affecting:
    • The Kentucky General Assembly’s recognition of translational science.
    • The University of Kentucky community (UK’s researchers, CCTS, staff, and partners) by publicly acknowledging their work and the value of translational science to Kentuckians.
  • No changes to laws, funding, or administrative authority are specified in the text.

Procedural and timeline notes

  • Introduction and sponsorship:
    • Introduced on March 5, 2026, in the Senate.
    • Co-sponsored by Senator Amanda Mays Bledsoe.
  • Committee action:
    • Referred to the Senate Committee on Committees (S) on March 5, 2026.
  • Floor action:
    • Adopted by voice vote in the Senate on April 15, 2026.
  • Effective date:
    • The designation takes effect as of the date of enactment (the resolution’s adoption date).

Context and significance

  • The resolution highlights Kentucky’s investment in translational science and UK’s leadership in this field.
  • It underscores the role of translational science in addressing health issues such as Alzheimer's disease and related dementias, cancer, cardiovascular disease, diabetes, and health disparities in Central Appalachia.
  • While non-binding (a resolution), it serves to raise public awareness, celebrate collaboration across researchers, clinicians, and community partners, and acknowledge collaborative efforts to improve health outcomes in Kentucky.

If you’d like, I can tailor this summary for a particular audience (policy makers, university leaders, or general public) or add a brief note on translational science concepts for readers unfamiliar with the term.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.